MNA
STJ

Manning & Napier Advisors’s St Jude Medical STJ Stock Holding History

Manning & Napier Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-35,664
Closed -$2.86M – 349
2016
Q4 		$2.86M Buy
35,664
+2,367
+7% +$188K 0.02% 250
2016
Q3 		$2.65M Buy
33,297
+410
+1% +$33.1K 0.02% 240
2016
Q2 		$2.56M Buy
+32,887
New +$2.35M 0.02% 239

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Manning & Napier Advisors's STJ Position: Q1 2017 in Review

Manning & Napier Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 35,664 shares — an estimated $2.86M sold.

Manning & Napier Advisors first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $2.86M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Manning & Napier Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Manning & Napier Advisors sold 35,664 St Jude Medical shares in Q1 2017, an estimated $2.86M.
  • Manning & Napier Advisors first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Manning & Napier Advisors's St Jude Medical position peaked at $2.86M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Manning & Napier Advisors's 13F filing for Q1 2017, filed 6 Apr 2017.